Anemia, Sickle Cell
Showing 9976 - 10000 of >10,000
Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,
Completed
- Hemophagocytic Lymphohistiocytosis
- +5 more
- Hematopoietic Stem Cell Transplant
-
Birmingham, Alabama
- +21 more
Dec 6, 2022
Type 2 Diabetes, Obesity, Bariatric Surgery Candidate Trial in Aurora (Aminohippurate Sodium Inj 20%, Iohexol Inj 300 mg/mL,
Recruiting
- Type 2 Diabetes Mellitus
- +11 more
- Aminohippurate Sodium Inj 20%
- +3 more
-
Aurora, ColoradoChildren's Hospital Colorado
Jan 28, 2022
Active Immune Response Trial in Klamath Falls (Herbal tea blend, Warm water)
Recruiting
- Active Immune Response
- Herbal tea blend
- Warm water
-
Klamath Falls, OregonGitte Jensen
Jun 29, 2021
Lymphoma, Mantle-Cell Trial in Czechia (Polatuzumab vedotin, Bendamustine Hydrochloride, Rituximab)
Not yet recruiting
- Lymphoma, Mantle-Cell
- Polatuzumab vedotin
- +2 more
-
Brno, Czechia
- +6 more
May 28, 2021
Non-Hodgkin's B-cell Lymphoma Trial in Tianjin (CD19/CD20-directed CAR-T cells)
Recruiting
- Non-Hodgkin's B-cell Lymphoma
- CD19/CD20-directed CAR-T cells
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hosipital
Jan 5, 2021
Irritable Bowel Syndrome-like Symptoms, Crohn Disease Remission Trial (BK003, Placebo)
Not yet recruiting
- Irritable Bowel Syndrome-like Symptoms
- Crohn Disease Remission
- BK003
- Placebo
- (no location specified)
Oct 23, 2023
Breast Cancer Trial in Beijing (99mTc-MY6349 SPECT/CT scan)
Recruiting
- Breast Cancer
- 99mTc-MY6349 SPECT/CT scan
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 24, 2023
Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee
Enrolling by invitation
- Monoclonal Gammopathy of Undetermined Significance
- +6 more
-
Milwaukee, WisconsinAurora Health Care
Jul 20, 2021
Renal Cell Carcinoma Trial in Philadelphia (drug, genetic, other, procedure)
Terminated
- Renal Cell Carcinoma
- Brivanib alaninate
- +5 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 18, 2021
Gastrointestinal Cancer, Lung Cancer, Pancreatic Cancer Trial (BI 765049, Ezabenlimab)
Not yet recruiting
- Gastrointestinal Cancer
- +5 more
- BI 765049
- Ezabenlimab
- (no location specified)
Oct 16, 2023
Diffuse B-Cell Lymphoma Trial in Worldwide (Avadomide (CC-122), Rituximab, Cyclophosphamide 750mg/m2 by IV infusion)
Completed
- Diffuse B-Cell Lymphoma
- Avadomide (CC-122)
- +4 more
-
Washington, District of Columbia
- +14 more
Apr 28, 2021
Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)
Active, not recruiting
- Hodgkin Lymphoma
- brentuximab vedotin
- +5 more
-
Fountain Valley, California
- +75 more
Dec 2, 2022
GVHD Trial run by the NHLBI (Topical Dexamethasone, Placebo)
Completed
- Graft vs Host Disease
- Topical Dexamethasone
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 20, 2022
Hematopoietic Stem Cell Transplantation Trial in Seoul (Mycophenolate Mofetil)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Mycophenolate Mofetil
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 29, 2021
Incisional Hernia, Medial Hernia, Medial-lateral Hernia Trial in Samara (A new method of repair of the abdominal wall of
Recruiting
- Incisional Hernia
- +2 more
- A new method of repair of the abdominal wall of mid-lateral postoperative ventral hernias
-
Samara, Russian FederationClinics of Samara State Medical University
Feb 8, 2023
Advanced or Metastatic Non-squamous NSCLC Trial (SHR-1701;BP102)
Not yet recruiting
- Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer
- (no location specified)
Jul 16, 2021
Special Care Patterns for Elderly HNSCC Patients Undergoing
Recruiting
- HNSCC
- +4 more
-
New York, New York
- +11 more
Jun 2, 2022
Fallopian Tube Carcinoma, Recurrent Ovarian Cancer, Primary Peritoneal Carcinoma Trial in Columbus (Lenvatinib Mesylate,
Completed
- Fallopian Tube Carcinoma
- +3 more
- Lenvatinib Mesylate
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 5, 2022
Stiff-Person Syndrome Trial in Chicago (Autologous Hematopoietic Stem Cells, Cyclophosphamide, Mesna)
Terminated
- Stiff-Person Syndrome
- Autologous Hematopoietic Stem Cells
- +6 more
-
Chicago, IllinoisNorthwestern University
Jan 6, 2021
Innate Lymphoid Cells in Peripheral Blood in ALS
Terminated
- Amyotrophic Lateral Sclerosis
- Blood draw
-
Ann Arbor, MichiganUniversity of Michigan
Dec 22, 2021
Extranodal NK/T-cell Lymphoma Trial in Korea, Republic of (VT-EBV-N, Placebo)
Recruiting
- Extranodal NK/T-cell Lymphoma
- VT-EBV-N
- Placebo
-
Busan, Korea, Republic of
- +7 more
Apr 28, 2022
Patients With Advanced Treatment Naive LCNEC Trial in Tel Aviv (Durvalumab)
Recruiting
- Patients With Advanced Treatment Naive LCNEC
-
Tel Aviv, IsraelAssuta MC
Feb 20, 2022
Multiple Myeloma Trial in Xuzhou (anti-BCMA/GPRC5D CAR-T CELL)
Recruiting
- Multiple Myeloma
- anti-BCMA/GPRC5D CAR-T CELL
-
Xuzhou, Jiangsu, ChinaKailin Xu
Aug 19, 2022